HOME >> MEDICINE >> NEWS
Implanted devices detect high-risk heart failure patients

DURHAM, N.C. Implanted devices intended to optimize the cardiac function of patients with heart failure have provided new insights into which patients might be at higher risk of dying suddenly from their disease, according to researchers at Duke University Medical Center.

Besides maintaining optimal electrical stimulation to the heart, these CRT-D (cardiac resynchronization therapy with defibrillation) devices are giving cardiologists a new view of subtle changes in a key measurement of heart health -- heart rate variability. Patients with little variability -- whose hearts are unable to appropriately react to external stimuli by regulating their beating action -- are known to be at higher risk of suffering a heart attack. The new insight from CRT-D devices is possible because they record detailed data on heart function 24 hours a day.

These new findings are important for two reasons, the researchers said. First, the collected information appears to more accurately identify high risk patients who would benefit from early and aggressive therapy. Secondly, the devices provide cardiologists with objective information about the health status of their patients, information that can be frustratingly difficult to obtain in a typical clinical setting in this medically diverse group of patients, the researchers said.

The results of the study were presented by Duke cardiologist Roosevelt Gilliam, M.D., March 7, 2005, at the annual scientific session of the American College of Cardiology in Orlando. "When you talk to heart failure patients, many times their perceptions of how they feel do not match with their actual clinical status, which can make it difficult for cardiologists to get a true idea of how the disease is progressing," said Gilliam, chief of electrophsysiology at Duke. "This study shows that changes in heart rate variability just might be better in picking out those people at highest risk."

In their analysis of 1,411 heart fa
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
7-Mar-2005


Page: 1 2 3

Related medicine news :

1. Implanted defibrillators cut heart patients death risk, some more than others
2. Implanted defibrillators not covered for half of patients who could benefit, study finds
3. Implanted stimulator for Parkinsons disease impairs cognitive function
4. Implanted defibrillators and anti-theft systems appear safe under normal circumstances
5. New guidelines conclude all aerosol therapy devices equally effective
6. Entrepreneurism Center at UC San Diego funds commercialization of lung, shock, other devices
7. Ventricular assist devices can be used as bridge to heart recovery without need for heart transplant
8. Scientists detail latest advances in development of prosthetic devices for paralyzed
9. New understanding of neural circuits may help development of thought-controlled prosthetic devices
10. Heart devices, transplants have similar costs; what will we pay?
11. Clot-buster keeps heart devices humming

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Implanted devices detect high risk heart failure patients

(Date:6/19/2013)... Dental professionals are increasingly monitoring end tidal ... moderate sedation, a patient’s breathing depth and rate decrease. ... latest to update its guidelines to require etCO2 monitoring, ... effort to increase safety in procedures. This amendment to ... into effect July 1. , The Oregon Board ...
(Date:6/19/2013)... June 19, 2013 Alternatives, a revolutionary ... patients to quit using drugs while allowing them to ... the founders of Alternatives, believe that abstinence-only approaches force ... enter treatment and that this approach hurts instead of ... in the United States need treatment for addiction but ...
(Date:6/19/2013)... 2013 Amerinet, Inc, a leading ... Technologies to help Pacific Medical Centers implement a ... more than 17 percent over the organization’s previous ... “Driving economies of scale and process standardization are ... facing multi-site providers,” said Shawn Padilla, director of ...
(Date:6/19/2013)... 19, 2013 Elsevier, a world-leading provider of ... announced today the publication of the National Osteoporosis ... management of osteoporosis in postmenopausal women and older ... Published in 2009 in Maturitas , the ... update is timely with an additional focus on ...
(Date:6/19/2013)... 2013 Imprivata ®, a leading ... that Imprivata OneSign ® leads the single sign-on ... Review: Software & Services report . CIOs and other ... the superior performance of its products and the quality ... that Imprivata is integral to their long-term healthcare IT ...
Breaking Medicine News(10 mins):Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently ... need to urgently address this issue has been emphasized by ... , "Medical device alarm safety in hospitals." According to The ... June 2012, there were 98 alarm related events reported, of ... , 13 resulted in permanent loss of function (13%) ...
(Date:6/19/2013)... Calif. , June 19, 2013  Finesse ... solutions for life sciences process applications, announced the ... bioreactors for upstream cell culture and fermentation.  The ... new product family of Finesse bioreactors and are ... cGMP applications.  They are fully compatible with all ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
Cached News: